STOMATOLOGY EDU JOURNAL 2017, Volume 4, Issue 3 SEJ_3-2017_Online - Page 56

Effective applications of botulinum toxin in dentistry and in head and neck surgery References 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. Chapman P. The global botox market forecast to reach $2.9 billion by 2018. http://www.businesswire.com/ news/home/20120515006631/en/Research-Markets- Global-Botox-Market-Forecast-Reach Roy D, Sadick NS. Complications of Botulinum Toxin. In: Gloster Jr. HM, Editor. Complications in Cutaneous Surgery. New York, NY. Springer; 2008. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope. 2001;111(2):218-226. doi: 10.1097/00005537- 200102000-00006 [Full text links] [PubMed] Apostolidis A, Popat R, Yiangou Y, et al. Decreased sensory receptors P2X 3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol. 2005;174(3):977-982; discussion 982-983. doi: 10.1097/01.ju.0000169481.42259.54 [Full text links] [PubMed] Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734–770. [Full text links] [Free PMC article] [PubMed] Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg. 1989;84(2):353-355. [PubMed] Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18(1):17-21. [PubMed] Information for Healthcare Professionals: OnabotulotoxinA (marketed as Botox/Botox Cosmetic), AbobotulotoxinA (marketed as Dysport) and RimabotulotoxinB (marketed as Myobloc). Food and Drug Ad ɅѥUѕMхѕ̤(̸)輽ܹؽ՝̽՝M)ÁЁȁЁ՝M%ɵѥAѥͅ)Aɽ٥̽՝M%ɵѥ!ѡɕAɽ̼ͥ)Ս乡Ѵ)Ḿ(؁AɕɼdḾЁUɽ)хЁ́ձմɽѽ᥸ѥ̸() ЁͽܠĤдԸmAՉ5t)M卡P-ɅՙMȁ@ ձմѽ᥸)ѡɕѵЁɅɔ幑ɽ聄)ѕѥɕ٥܁ѡѕɅɔ(9ɽ)M$mձѕЁtmɕA5 ѥt)mAՉ5t))ͽ)0-ɥ兵!͡d ձմ)ѽ᥸ȁɽ居ѥɕѵЁɅ)ѕͥ́ձ聄ф̸ͥ)5(ܠؤشԸĽȸԸ)mձѕЁtmɕA5 ѥtmAՉ5t)餁]͕ɵQɕѵЁɕͥ)ݥѠձմѽ᥸聄͔͕ɥ̸ɵѽ)MɜȠԤԴ쁑͍ͥ(ĽдԸظعmձѕЁt)mAՉ5t)-(ɱ1)@Ё ձմѽ᥸)ɕѵЁȁɱɥѥ͕ѼɅ)ɕɅѕ͕ٕѠٔ䁽ȁͅم䁝)Ʌхѥ ȁ(=ѡؠĤ̴ظ)mɕձѕtmɕA5 ѥtmAՉ5t(и$ȁ-, 8!ͥȁI0)ȸ!́ͥ)٥́ѡɅͥ̀ 䤸)5(̠ؤܴmձѕЁtmAՉ5t(Ը$Aɬ5d-d)չL ձմѽ᥸)ɕѵЁȁѽɥѡݕȁɵѽ)MɜԤܴ쁑̸͍ͥmձѕ)tmAՉ5t(ظ$Q,)٥(Qɕѥ͕ٕɔʹݥѠ)ձմѽ᥸(ЁͽĠȤĴ(ظmձѕЁtmAՉ5t(ܸ$5ɔ@]QЁ)͕ѕɥɽݥѠձմѽ᥸) ȁ(=Ʌ5ᥱMɜȠĤشกmAՉ5t($AͅՐHɅ́MلLЁ٥͕)ɕ٥܁ձմѽ᥸ ѽँѥ́)͵ѥѥ̸)IM4MЁI(РȤܼԸmɕ)A5 ѥtmAՉ5t($ 0(m ʹѕɼձ)͙չѥձմѽ᥹tIЁ5)A̸ؠؤ̴ܸmձѕЁtmAՉ5t($kť LAє5 )́ձմѽ᥸ɥ)Ʌā9ɽͥեȸؠ̸)mձѕЁtmAՉ5t(ĸ$́4ѕTIɉYLЁ)IՍѥͅم䁙܁ݥѠձմѽ᥸)ѕɕЁ́ѥ́ݥѠɽ)ͅم䁙ձ̰ͥѥ̸1幝͍(Рشܼܴ(́mձѕЁtmAՉ5t(ȸ$ Q́8AձYɹф ɏ )(5ɍɄ(=ѥٔѥ́ɽх)彍̸U͔ձմѽ᥸聄͔ɕи)ф=ѽɥɥ̠ԤĴȸ(ؽѽɤĸȸЁmձѕЁtmɕձ)ѕtmAՉ5t(̸$A4 ձմѽ᥸ ѽँȁѡ)ɽ͍ձȁɕѥፕͥٔم)͵յ͵(=ѡѽ)=ѡ(̠ȤԴ̸)(ؽ)ܸи̸mձѕЁtmAՉ5t(и$1!Ց9$ ѽ́չЁѼ)ɕͥѥȁѡЁፕͥٔم)䁥ѡɕ͕ɵ䁽)ٕѥᥱ䁕ፕ̸ЁÍ(%͙(̠ؤ̸mձѕЁtmɕA5 ѥt)mAՉ5t(Ը$]Tمѥѡɹȁ)ѡѠͥձմѽ᥸( х)ѡЁMɜ̠̤Դ̼д(ܸmɕձѕtmɕA5 ѥtmAՉ5t(ظ$ԁ<呥M٥LЁUɅͽչ)եٕ̃adɅɽѥѥ́)ձմѽ᥸ȁѡɕѵЁͥɡ)ѥ́ݥѠAɭͽé͕͔ 9ɽ)9ɽɜؠȤ̴ظ(ؽ)ɼ̸ȁmձѕЁtmAՉ5t)I5U 1H)LAͽєAɽͽ)ѵЁMѽѽ)5ձ䰁 ɱ́Uٕͥ)AɅՔ 镍IՉ) X)IՍȁɅՅѕɽѡЁM5 ɱ́Uٕͥ䰁AɅՔ!́=ɅMɝ)Ёѡѥ1͕ȁ5AP Q`1͕̰х̤́ݕ́ɽͽȁ)5 ̸ͥͽєAɽͽȁЁ ɱ́UٕͥAɅՔͽєAɽͽȁЁUٕͥ䁽A()Mɥ-ͥAɕͥЁѡ 镍х ȸ ȁѡ 镍M䁽ѡѥ1͕)5 ɐȁ%5 L5ȁȁ܁ѡɥM䁙ȁ1͕ȁ5)Mɝ䰁%M15Lɥ䁽%Ёѥ䀡%ɥ䁽 ͵ѥ)ѥ䀡 1()Mѽԁ(Р̤)輽ܹѽը